Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

EGFR T790M Mutation Positive NSCLC × Thoracic × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6100 Lung Neoplasms 4518 Small Cell Lung Carcinoma 1010 Breast Neoplasms 752 Neoplasms 691 Colorectal Neoplasms 583 Melanoma 486 Ovarian Neoplasms 442 Neoplasm Metastasis 416 Pancreatic Neoplasms 415 Adenocarcinoma of Lung 355 Stomach Neoplasms 341 Prostatic Neoplasms 330 Head and Neck Neoplasms 320 Carcinoma, Renal Cell 302 Mesothelioma, Malignant 292 Esophageal Neoplasms 287 Squamous Cell Carcinoma of Head and Neck 283 Mesothelioma 259 Colonic Neoplasms 257 Urinary Bladder Neoplasms 232 Brain Neoplasms 224 Uterine Cervical Neoplasms 200 Triple Negative Breast Neoplasms 193 Sarcoma 173 Endometrial Neoplasms 171 Carcinoma, Hepatocellular 153 NSCLC 151 Carcinoma 142 Pleural Effusion, Malignant 140

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02451852 2016-07-14

AZD9291 US Expanded Access Program

AstraZeneca

No longer available

EGFR T790M Mutation Positive NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡